In vivo activity of the dual PI3Kδ and PI3Kγ inhibitor duvelisib against pediatric acute lymphoblastic leukemia xenografts.

Joanna RandallKathryn EvansBen WattsChristopher M SmithKeira HughesEric Jay EarleyStephen W EricksonJonathan A PachterBeverly A TeicherMalcolm A Smith Richard B Lock

Published in: Pediatric blood & cancer (2023)

Duvelisib demonstrated limited in vivo activity against ALL PDXs.

Keyphrases